2019
Evaluating the Integrated Methadone and Anti-Retroviral Therapy Strategy in Tanzania Using the RE-AIM Framework
Hassan S, Cooke A, Saleem H, Mushi D, Mbwambo J, Lambdin BH. Evaluating the Integrated Methadone and Anti-Retroviral Therapy Strategy in Tanzania Using the RE-AIM Framework. International Journal Of Environmental Research And Public Health 2019, 16: 728. PMID: 30823440, PMCID: PMC6427450, DOI: 10.3390/ijerph16050728.Peer-Reviewed Original ResearchConceptsOpioid treatment programsRE-AIM frameworkHIV servicesOTP clinicART initiationTherapy strategiesART initiation ratesHIV care deliveryHIV-positive clientsRE-AIM componentsHIV diagnosisImplementation science frameworkHIV prevalenceSaharan AfricaEligible clientsProgrammatic dataCare deliveryTreatment programProtocol fidelityDar es SalaamInitiation rateMethadoneClinicIMATSemi-structured interviewsPatient and provider perspectives on implementation barriers and facilitators of an integrated opioid treatment and HIV care intervention
Cooke A, Saleem H, Hassan S, Mushi D, Mbwambo J, Lambdin B. Patient and provider perspectives on implementation barriers and facilitators of an integrated opioid treatment and HIV care intervention. Addiction Science & Clinical Practice 2019, 14: 3. PMID: 30691511, PMCID: PMC6350287, DOI: 10.1186/s13722-019-0133-9.Peer-Reviewed Original ResearchConceptsOpioid treatment programsOTP clinicIntervention characteristicsHIV servicesHIV care interventionsHIV-positive PWUDAntiretroviral therapy initiationHIV-positive patientsOTP providersCare contextLow-resource settingsDar es Salaam TanzaniaSpecific care contextsOTP patientsOpioid treatmentTherapy initiationSuccess of interventionsCare interventionsNeeds of providersPatient educationClinic workloadPatientsTherapy interventionOuter settingIntervention protocol
2017
Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania
Lambdin BH, Lorvick J, Mbwambo JK, Rwegasha J, Hassan S, Lum P, Kral AH. Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania. International Journal Of Drug Policy 2017, 45: 64-69. PMID: 28628854, PMCID: PMC6166640, DOI: 10.1016/j.drugpo.2017.05.043.Peer-Reviewed Original ResearchConceptsOpioid treatment programsHepatitis C virusOTP clinicHCV antibodiesAntibody serostatusHCV careDar es SalaamTreatment programHCV antibody prevalenceMultivariable Poisson regressionCross-sectional studyRoutine programmatic dataHIV-positiveMiddle-income countriesAdjusted analysisHIV servicesLast injectionMethadone patientsTreatment patientsC virusLeading causeAntibody prevalenceOverall seroprevalenceHigh burdenPWID